Chilton Capital Management LLC Merck & Co., Inc. Transaction History

Chilton Capital Management LLC

$2.19 Billion
Q2 2024

A detailed history of Chilton Capital Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Chilton Capital Management LLC holds 268,085 shares of MRK stock, worth $30.4 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares

268,085

Previous 251,814 6.46%

Holding current value

$30.4 Million

Previous $33.2 Million 0.11%

% of portfolio

1.52%

Previous 1.61%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$123.8 - $132.96 $2.01 Million - $2.16 Million	16,271 Added 6.46%	268,085 $33.2 Million
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $996,625 - $1.16 Million	8,801 Added 3.62%	251,814 $33.2 Million
Q4 2023 Jan 18, 2024	BUY	$100.18 - $109.02 $20.8 Million - $22.6 Million	207,243 Added 579.38%	243,013 $26.5 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $10,809 - $12,004	105 Added 0.29%	35,770 $3.68 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $120,774 - $131,638	1,112 Added 3.22%	35,665 $4.12 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $92,954 - $103,718	903 Added 2.68%	34,553 $3.68 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $377,565 - $484,090	-4,318 Reduced 11.37%	33,650 $3.73 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $20,794 - $23,360	-246 Reduced 0.64%	37,968 $3.27 Million
Q2 2022 Aug 16, 2022	SELL	$83.49 - $94.64 $28,470 - $32,272	-341 Reduced 0.88%	38,214 $3.48 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $308,080 - $345,338	-4,191 Reduced 9.8%	38,555 $3.16 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $79,508 - $99,594	-1,100 Reduced 2.51%	42,746 $3.28 Million
Q3 2021 Nov 04, 2021	BUY	$71.68 - $78.83 $9,533 - $10,484	133 Added 0.3%	43,846 $3.29 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $338,612 - $374,540	4,816 Added 12.38%	43,713 $3.4 Million
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $3,787 - $4,461	55 Added 0.14%	38,897 $3 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $756,388 - $857,371	10,336 Added 36.26%	38,842 $3.22 Million
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $45,773 - $52,084	-650 Reduced 2.23%	28,506 $2.2 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $5,068 - $7,025	-80 Reduced 0.27%	29,156 $2.24 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $114,973 - $129,734	-1,482 Reduced 4.82%	29,236 $2.66 Million
Q3 2019 Nov 15, 2019	SELL	$76.08 - $82.93 $46,256 - $50,421	-608 Reduced 1.94%	30,718 $2.59 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $9,498 - $11,096	-136 Reduced 0.43%	31,326 $2.63 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $1.44 Million - $1.64 Million	-20,690 Reduced 39.67%	31,462 $2.62 Million
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $468,684 - $543,900	-7,184 Reduced 12.11%	52,152 $3.99 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $16,499 - $19,402	-286 Reduced 0.48%	59,336 $4.21 Million
Q2 2018 Oct 10, 2018	BUY	$50.83 - $59.72 $1.31 Million - $1.54 Million	25,757 Added 76.06%	59,622 $3.61 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $1.31 Million - $1.54 Million	-25,852 Reduced 43.29%	33,865 $2.06 Million
Q1 2018 Oct 09, 2018	BUY	$50.96 - $59.23 $1.32 Million - $1.53 Million	25,900 Added 76.59%	59,717 $3.24 Million
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $1.47 Million - $1.7 Million	-28,754 Reduced 45.95%	33,817 $1.84 Million
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $5.5 Million - $6.57 Million	-106,617 Reduced 63.02%	62,571 $3.52 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $9.93 Million - $10.7 Million	169,188	169,188 $10.8 Million

Others Institutions Holding MRK

# of Institutions

3,831

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.

Account

Chilton Capital Management LLC Merck & Co., Inc. Transaction History